Vitrectomy Machines Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Vitrectomy Machines, Vitrectomy Packs, Microscopic Illumination Equipment, Surgical Instruments, and Others), By Application (Retinal Detachment, Diabetic Retinopathy, Trauma, Macular Surgery, Pediatric Retinal Disorders, and Others), By End User (Hospitals, Eye Clinics, and Others), and Region Forecast 2020-2031

Vitrectomy Machines Market size was valued at US$ 494.1 million in 2024 and is expected to reach US$ 803.9 million by 2031, growing at a significant CAGR of 7.2% from 2025-2031. Vitrectomy machines are devices commonly employed in vitreoretinal surgery used to treat problems of the eye’s retina and vitreous such as retinal detachments, vitreous hemorrhage, endophthalmitis, and macular holes in a controlled, closed system. According to the Wenzhou Statistical report, the incidence of retinal detachment was 7.79 cases per 100,000 population. The increased number of trauma cases related to retinal tear and diabetic retinopathy are expected to drive the vitrectomy machines market. According to WHO, the prevalence of diabetic retinopathy among diabetic patients is estimated to be 27.0%, which leads to 0.4 million blindness in the world leading to the growth of the market.

Moreover, the technological advancement in visualization systems including operating microscopes, 3D heads-up display systems, and viewing systems such as endoscopic vitrectomy with higher cut rates are providing several opportunities for the development of the market. For instance, in 2019, the HYPERVIT two-blade vitrectomy probe was introduced by Alcon, a major leader in the eye care industry.  The discovery of new innovative surgical procedures and the association of these procedures with deep learning algorithms are also expected to contribute to the growth in the global market over the forecast period.

Furthermore, the market is expanding as a result of increased government attention on providing improved healthcare facilities and adequate patient care, expansion potential for vitrectomy machines, and rising use of diagnostic vitrectomy devices. For instance, the Indian government launched a National Programme for the Control of Blindness and Visual Impairment (NPCBVI) with an aim to reduce the prevalence of blindness from 1.4% to 0.3 %. But the risk associated with vitrectomy and the increased chances of patients undergoing vitrectomy developing cataracts in a few years is restraining the growth of the market. Moreover, the higher cost of surgeries and instrumentation is also hampering the growth of the market. However, the presence of reputable research institutions engaged in product development, the rising prevalence of diabetic retinopathy and vitreous hemorrhage, increased healthcare spending per capita, and advanced diagnostic technologies all support expansion of the market over the forecast years.

Key Developments

• In May 2021, MedOne Surgical announced the FDA 510(k) clearance of its MicroDose Injector device for low Hoya Surgical Optics acquired Fritz Ruck and MID Labs. This acquisition allowed Hoya to leverage MID Lab’s vitrectomy cutters, machines, and other vitreoretinal surgical products -volume ophthalmic injections into the subretinal space.
• In January 2019, Hoya Surgical Optics acquired Fritz Ruck and MID Labs. This acquisition allowed Hoya to leverage MID Lab’s vitrectomy cutters, machines, and other vitreoretinal surgical products.